Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P Biotech ETF
XBI
|
+$284M |
| 2 |
Constellation Brands
STZ
|
+$284M |
| 3 |
Stellantis
STLA
|
+$268M |
| 4 |
VMW
VMware, Inc
VMW
|
+$263M |
| 5 |
NiSource
NI
|
+$234M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$1.82B |
| 2 |
Apple
AAPL
|
+$1.62B |
| 3 |
UnitedHealth
UNH
|
+$1.03B |
| 4 |
ExxonMobil
XOM
|
+$869M |
| 5 |
Tesla
TSLA
|
+$701M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.19% |
| 2 | Consumer Discretionary | 5.03% |
| 3 | Healthcare | 4.78% |
| 4 | Financials | 4.74% |
| 5 | Communication Services | 2.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3951
Global X Uranium ETF
URA
$5.42B
| $119K | ﹤0.01% |
5,970
+3,470
| +139% | +$73.4K |
|
3952
Kodak
KODK
$822M
| $119K | ﹤0.01% |
28,986
+13,638
| +89% | +$49.2K |
|
3953
Bassett Furniture
BSET
$164M
| $119K | ﹤0.01% |
6,665
| – | – |
|
3954
Eagle Bancorp Montana
EBMT
$187M
| $119K | ﹤0.01% |
8,402
| – | – |
|
3955
Ouster
OUST
$2.63B
| $118K | ﹤0.01% |
14,145
+10,249
| +263% | +$119K |
|
3956
Monte Rosa Therapeutics
GLUE
$1.4B
| $118K | ﹤0.01% |
15,169
+7,181
| +90% | +$49.9K |
|
|
ATCX
3957
DELISTED
Atlas Technical Consultants, Inc. Class A Common Stock
ATCX
| $118K | ﹤0.01% |
9,693
+4,549
| +88% | +$46.4K |
|
|
AFMD
3958
DELISTED
Affimed
AFMD
| $118K | ﹤0.01% |
15,821
+4,337
| +38% | +$43.4K |
|
3959
Nerdy
NRDY
$106M
| $118K | ﹤0.01% |
28,194
+13,205
| +88% | +$40.4K |
|
3960
Core Molding Technologies
CMT
$202M
| $118K | ﹤0.01% |
+6,533
| New | +$102K |
|
3961
Liberty Broadband Class A
LBRDA
$4.89B
| $117K | ﹤0.01% |
1,430
-195
| -12% | -$16.8K |
|
3962
Eldorado Gold
EGO
$7.87B
| $117K | ﹤0.01% |
11,300
-4,700
| -29% | -$43.8K |
|
|
RJAC
3963
DELISTED
Jackson Acquisition Company
RJAC
| $117K | ﹤0.01% |
11,316
| – | – |
|
3964
AlTi Global
ALTI
$399M
| $116K | ﹤0.01% |
9,244
-490,756
| -98% | -$4.94M |
|
|
ETNB
3965
CALL
DELISTED
89bio
ETNB
| $116K | ﹤0.01% |
+7,600
| New | +$99.1K |
|
|
THRX
3966
DELISTED
Theseus Pharmaceuticals, Inc. Common Stock
THRX
| $115K | ﹤0.01% |
12,993
+4,089
| +46% | +$40.1K |
|
3967
Comp X International
CIX
$349M
| $115K | ﹤0.01% |
6,380
+371
| +6% | +$6.82K |
|
3968
Ranpak Holdings
PACK
$439M
| $115K | ﹤0.01% |
22,031
+10,364
| +89% | +$65.8K |
|
3969
RBB Bancorp
RBB
$448M
| $115K | ﹤0.01% |
7,413
+3,485
| +89% | +$66.7K |
|
3970
Consolidated Water Co
CWCO
$467M
| $115K | ﹤0.01% |
6,987
-130
| -2% | -$1.93K |
|
3971
Vanguard Morningstar Small-Cap Growth ETF
VBK
$23.1B
| $115K | ﹤0.01% |
530
| – | – |
|
|
HRT
3972
DELISTED
HireRight Holdings Corporation
HRT
| $114K | ﹤0.01% |
10,721
-24,521
| -70% | -$276K |
|
|
RJET
3973
Republic Airways Holdings
RJET
$967M
| $114K | ﹤0.01% |
+3,196
| New | +$134K |
|
|
IGMS
3974
DELISTED
IGM Biosciences
IGMS
| $113K | ﹤0.01% |
8,259
+2,498
| +43% | +$51.7K |
|
|
WW
3975
DELISTED
WW International
WW
| $113K | ﹤0.01% |
27,531
+1,436
| +6% | +$6.28K |
|
Similar funds
Barclays's Q1 2023 Portfolio in Review
As of Q1 2023, Barclays held 5,603 positions worth $218B, down 2.4% from $223B the previous quarter. Its ten largest holdings account for 47% of the portfolio.
Barclays withdrew a net $25.1B in Q1 2023, closing 541 positions and reducing 1,667 holdings. Its most notable exit was Coupa Software Incorporated, an estimated $128M position sold in full.
By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 12% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, Barclays opened a new position in GE HealthCare worth $40.7M.
- Barclays's largest Q1 2023 buy was GE HealthCare: 496,712 shares worth $40.7M.
- Barclays added most to State Street SPDR S&P Biotech ETF in Q1 2023, an estimated $284M increase.
- Barclays's biggest Q1 2023 reduction was Microsoft, cutting an estimated $1.82B.
- Barclays fully exited Coupa Software Incorporated in Q1 2023, selling an estimated $128M.
- Barclays's ten largest holdings make up 47% of its $218B portfolio in Q1 2023.
- Barclays opened 345 new positions and closed 541 in Q1 2023.
- Barclays's portfolio value fell 2.4% quarter-over-quarter to $218B.
Based on Barclays's 13F filing for Q1 2023, filed 4 May 2023.